PHusis Delivers Novel PH-Domain Inhibitors for the Treatment of Cancer

PHusis Therapeutics is developing novel targeted small molecule therapeutics that bind and block the pleckstrin homology (PH)-domain of critical signaling proteins involved in driving cancer cell growth and survival.

Learn more.

About PHusis Technology PH domains